Medical Device Procurement in Ireland: A Supplier's Guide [2026]

Ireland occupies a uniquely important position in the global medical device industry: it is the largest medtech exporter in Europe by per-capita value and hosts the European operations of nine of the world’s ten largest medical device companies. Medtronic, Boston Scientific, Stryker, Abbott, Johnson & Johnson MedTech, Cook Medical, Becton Dickinson, Edwards Lifesciences, and Teleflex all maintain significant manufacturing or commercial operations in Ireland. The country manufactures approximately 12% of all medical devices used across Europe. Yet despite this dominant role in medtech manufacturing and export, the domestic Irish hospital procurement market — buying for Ireland’s own public health system — is often overlooked by foreign suppliers building EU market entry strategies.

This guide covers Ireland’s regulatory framework, procurement system, and practical strategies for winning Irish hospital tenders.

Regulatory authority and approval pathway

Ireland operates fully under the EU Medical Device Regulation (MDR 2017/745). The national competent authority is the Health Products Regulatory Authority (HPRA), responsible for:

• Market surveillance and vigilance reporting under EU MDR and IVDR
• Issuing special authorisations for devices not yet holding EU MDR certification in urgent clinical need situations
• Coordinating with the European Commission and other national competent authorities through the MDCG (Medical Device Coordination Group)
• Conducting post-market surveillance inspections and enforcement actions against non-compliant devices in the Irish market

HPRA has an active market surveillance programme and coordinates with HSE procurement to identify non-compliant products in the Irish supply chain. Ireland’s regulatory environment reflects the country’s deep medtech industry expertise and the concentration of major global manufacturers subject to HPRA oversight.

Market access requirements for Ireland:

• CE marking under EU MDR: Mandatory for all devices placed on the Irish market. HPRA does not accept MDD-era certificates for new market placements. Valid EU MDR Notified Body certification is the baseline requirement.
• EUDAMED registration: All devices must be registered in EUDAMED with UDI assigned at the required packaging levels. Irish hospital procurement increasingly cross-references EUDAMED as part of supplier qualification screening.
• EU Authorised Representative: Non-EU manufacturers must appoint an EU Authorised Representative under Article 11 of EU MDR. Ireland’s substantial regulatory affairs consultancy sector means Irish-based EU Authorised Representatives are widely available — an arrangement that can support both compliance and commercial market relationships simultaneously.
• HPRA vigilance reporting: Serious incidents must be reported to HPRA within EU MDR timelines. HPRA’s active vigilance database means compliance history is visible to HSE procurement and can affect supplier qualification standing in major framework tenders.

If your EU MDR conformity assessment is in order, Ireland’s regulatory pathway is the standard EU MDR route. The distinctive aspects of Irish market entry are the HSE procurement structure, HIQA health technology assessment, and Ireland’s clinical reference site network.

Ireland’s health system and hospital structure

The Health Service Executive (HSE) is Ireland’s national public health authority, operating one of the most centralised healthcare systems in the EU. The HSE manages approximately 50 acute public hospitals, 4,000 primary care facilities, and an extensive community health infrastructure. Public hospitals are organised into six Hospital Groups:

• RCSI Hospital Group: Beaumont Hospital (major neurosurgery, cardiothoracic, transplant centre), Connolly Hospital, Our Lady of Lourdes Hospital, Cavan General, and others in the north-east.
• Ireland East Hospital Group: St Vincent’s University Hospital (transplantation, cardiology, oncology, diabetes), the Mater Misericordiae University Hospital (cardiac surgery, neurology, respiratory), and St Luke’s Radiation Oncology Network.
• University of Limerick Hospitals Group: University Hospital Limerick — the largest emergency and acute care hospital in the mid-west, with significant cardiac and orthopaedic volumes.
• Saolta University Health Care Group: University Hospital Galway (cardiac surgery, oncology, renal), Mayo University Hospital, Sligo University Hospital, and others serving the west and north-west.
• South/South West Hospital Group: Cork University Hospital (cardiac surgery, trauma, orthopaedics, cancer), Mercy University Hospital, and University Hospital Kerry.
• Children’s Health Ireland (CHI): The new National Children’s Hospital in Dublin — one of Europe’s largest children’s hospitals — plus CHI at Crumlin (cardiac surgery, oncology, neurosurgery) and CHI at Temple Street. CHI is one of Ireland’s most significant ongoing procurement opportunities for paediatric devices, neonatal equipment, and specialist surgical systems.

Ireland also has a significant private hospital sector — Blackrock Health, Mater Private, Beacon Hospital, Hermitage Medical Clinic, and Bon Secours Health System. Private hospital procurement operates outside HSE frameworks but follows broadly similar clinical standards and compliance requirements.

Key procurement platforms and channels

• eTenders.gov.ie: Ireland’s national public procurement portal, managed by the Office of Government Procurement (OGP). All public contracts above EU threshold values (currently EUR 215,000 for goods and services) must be published on eTenders and simultaneously on TED (Tenders Electronic Daily). eTenders is the primary monitoring portal for Irish medical device procurement.
• HSE National Procurement: The HSE operates a dedicated national procurement office that coordinates framework agreements for high-volume consumables, diagnostics, and capital equipment. HSE national frameworks are competitively tendered through eTenders; awarded framework suppliers can supply multiple hospitals without individual hospital-by-hospital tendering. A position on an HSE national framework is the highest-efficiency commercial pathway in the Irish public hospital market.
• OGP Health Frameworks: The Office of Government Procurement manages cross-government frameworks for certain health sector categories — progressively expanding beyond the HSE’s own framework structure. Monitoring OGP tender pipelines alongside HSE-specific frameworks is important for full market coverage.
• Individual Hospital Group and hospital tenders: Below-threshold and specialised device procurement is conducted at Hospital Group and individual hospital level. Academic hospitals — St Vincent’s University Hospital, Beaumont Hospital, Cork University Hospital — run their own procurement processes for novel devices, research-linked procurement, and specialised clinical equipment not covered by national frameworks.
• TED (Tenders Electronic Daily): All contracts above EU thresholds appear on TED, providing a European-level view of Irish public procurement. Monitoring TED alongside eTenders ensures comprehensive coverage.

MedStrato’s tender monitoring consolidates Irish procurement opportunities from eTenders, TED, and Hospital Group portals into a single feed, with EU MDR compliance verification automated for each opportunity.

Compliance requirements for Irish hospital tenders

• EU MDR compliance documentation: Valid CE certificate under EU MDR, Declaration of Conformity referencing MDR 2017/745, EUDAMED UDI registration, and — for Class IIb and III devices — SSCP. See the EU MDR tender requirements 2026 checklist for the complete document set.
• ISO 13485 certification: QMS certification from an accredited body is standard for HSE framework qualification. Some HSE frameworks include additional standard requirements specific to device categories (EN ISO 14971 risk management, IEC 62304 for software-enabled devices).
• Health Technology Assessment (HTA): HIQA (Health Information and Quality Authority) conducts HTAs that inform HSE procurement decisions for higher-value devices and novel technologies. HIQA’s Early Assessment programme allows suppliers to engage proactively before a formal HTA is commissioned. For capital equipment and novel interventional devices, early HIQA engagement significantly accelerates hospital adoption.
• Language: English throughout. Ireland is the only EU member state where English is the primary official procurement language — a material advantage for English-language suppliers compared to competing in Germany, France, or Spain.
• Financial standing: HSE and OGP framework qualification requires audited accounts and bank references as evidence of financial standing, consistent with EU public procurement directives.
• Insurance: Public liability and product liability insurance certificates are standard requirements. HSE frameworks specify minimum coverage levels for medical device categories.

Market size and opportunity

Ireland’s domestic medical device market is valued at approximately EUR 1.5–2 billion annually in healthcare expenditure terms. Despite a population of 5.1 million, per-capita medical device expenditure is among the highest in the EU, reflecting the quality of its public hospital system and concentration of clinical expertise in academic medical centres. Key opportunity segments:

• Surgical and interventional devices: Ireland’s academic hospitals are active adopters of advanced surgical systems. Beaumont Hospital (neurosurgery, cardiothoracic), St Vincent’s University Hospital (transplantation, oncology, cardiology), and Cork University Hospital (cardiac surgery, orthopaedics) are high-volume procurement centres for complex surgical devices.
• Diagnostics and point-of-care: The HSE has prioritised diagnostics investment since 2021. Point-of-care testing, clinical chemistry analysers, and molecular diagnostics represent significant ongoing procurement volume. National laboratory frameworks are managed by the HSE’s National Pathology Programme.
• Children’s Health Ireland: The National Children’s Hospital procurement programme — covering paediatric devices, neonatal care equipment, and specialist surgical systems — represents one of the largest sustained procurement opportunities in the Irish market over the next decade as CHI reaches full operational capacity and equips all facilities to international academic children’s hospital standards.
• Digital health and Software as a Medical Device (SaMD): The HSE’s Digital Transformation Programme is one of the most ambitious healthcare digitisation programmes in Europe, driven partly by the 2021 ransomware attack that exposed critical infrastructure vulnerabilities. Investments in electronic health records, clinical decision support, telehealth, and connected medical devices create substantial procurement opportunities for CE-marked SaMD suppliers with strong cybersecurity credentials.
• Home care and community devices: Ireland’s significant home care sector (chronic disease management, diabetes monitoring, respiratory, wound care) is procured through both HSE community care frameworks and private health insurers (VHI, Laya Healthcare, Irish Life Health). This dual procurement structure — public and private — provides complementary volume pathways.

Ireland as a strategic European medtech hub

Beyond the domestic market, Ireland’s position in the global medtech supply chain creates strategic value for EU market entry that extends well beyond winning Irish hospital tenders:

• Clinical reference sites: With nine of the world’s ten largest medtech companies operating in Ireland, Irish hospitals frequently serve as preferred European clinical evaluation and first-in-class adoption sites for global device launches. A clinical adoption at Beaumont Hospital or St Vincent’s University Hospital is recognised as a credible EU reference by procurement authorities across the continent.
• KOL network: Ireland’s medical community includes internationally recognised Key Opinion Leaders in cardiology (St Vincent’s), neurosurgery (Beaumont), cardiac surgery (Cork University Hospital), and orthopaedics (UPMC Cappagh National Orthopaedic Hospital). Establishing KOL relationships in Ireland frequently generates broader EU market influence.
• IDA Ireland support: The Industrial Development Authority (IDA Ireland) actively supports both manufacturing FDI and commercial operations development in the Irish medtech sector. IDA can facilitate introductions to HSE procurement leadership, academic hospital technology committees, and Irish medtech industry networks — a commercially underused resource for foreign suppliers seeking Irish market presence.
• Regulatory talent pool: Ireland has one of the highest concentrations of regulatory affairs, quality engineering, and clinical applications professionals in Europe, built over 40 years of global medtech manufacturing. Hiring or partnering with Irish regulatory and commercial talent provides immediate EU market credibility and domain knowledge.

Tips for foreign suppliers entering Ireland

1. Register on eTenders from day one: All HSE and OGP public procurement notifications are published on eTenders. Suppliers not registered on eTenders miss every public opportunity. Registration is free, and the platform publishes Prior Information Notices (PINs) for upcoming major tenders — useful for planning ahead of formal publication and for engaging at the framework design stage.
2. Target HSE national framework positions: A position on an HSE national framework for your product category provides access to all 50+ acute public hospitals through a single commercial process. Monitor eTenders for framework establishment notices and respond to RFIs (Requests for Information) when frameworks are being designed — early engagement can influence evaluation criteria in your favour.
3. Engage HIQA early for higher-value devices: Rather than waiting for HIQA to commission an HTA reactively, use HIQA’s Early Assessment programme for novel technologies. Early engagement shapes the evaluation framework and demonstrates long-term commitment to the Irish market.
4. Use the English-language advantage strategically: Ireland is the only EU member state where English is the primary official tender language. Use this advantage to produce thorough, well-structured, clinically compelling tender submissions. Irish hospital procurement committees are sophisticated clinical buyers — the quality of clinical evidence presentation in your submission matters.
5. Leverage Irish academic hospitals as EU-wide clinical references: A pilot programme or clinical evaluation agreement with an Irish hospital generates clinical reference value that is recognised across the EU. Plan Irish market entry as part of a broader EU clinical evidence strategy, not just as a standalone market opportunity. Book a MedStrato demo to see how automated tender monitoring across Ireland, the UK, and EU markets enables coordinated multi-market commercial execution.

Common rejection reasons in Irish hospital tenders

The most frequent technical rejection reasons in Irish hospital procurement include:

• EU MDR NB certificate expiry before the end of the framework agreement period
• Declaration of Conformity still referencing MDD 93/42/EEC rather than MDR 2017/745
• Incomplete EUDAMED UDI registration — particularly missing DI at carton or shipping container level for products where these are specified in the tender
• ISO 13485 certificate from a body not accredited by an IAF-recognised accreditation body
• Financial standing documentation not in the correct format (audited accounts older than 36 months not accepted by HSE frameworks)
• Insufficient clinical evidence for Class IIb and III devices in tenders with HIQA-aligned clinical evaluation criteria
• Missing or inadequate product liability insurance coverage for the Irish market

Most compliance failures in Irish tenders are preventable with proper pre-submission review. MedStrato automates compliance verification against each tender’s specific requirements before submission, flagging expiry risks, documentation gaps, and EUDAMED inconsistencies in real time.

Ready to pursue Irish hospital tenders? Book a demo to see how MedStrato handles Irish tender monitoring and EU MDR compliance verification, or explore the full feature set for multi-market medical device tender management.